← Leaderboards
Todd C. Skaar
Indiana University Indianapolis
$14,016,309
Attributed
$21,677,604
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2009–25$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$21,677,604 · 8
By mechanism
U01$13,630,852 · 3
R01$5,463,221 · 2
R35$2,480,625 · 1
P30$102,906 · 2
Top collaborators
- Paul Dexter17 shared
- Yunlong Liu3 shared
Most similar at Indiana University Indianapolis
Same institution · by research overlap
- Michael Thomas Eadon$6,752,437
- Luis M Rocha$1,021,469
- Hagit Shatkay$1,839,849
- Tyler A Shugg$669,059
- Yunlong Liu$11,392,809
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsGenomicsGenetic VariantBaseResponseEnzymesAffectGenotypeClinical TrialsGenesIndianaResearch PersonnelPharmacologyProspectiveUniversitiesSafetyProviderRandomizedPharmacogenomicsPharmacotherapyUnderserved PopulationCyp2d6 GeneLiverToxic Effect
Grant awards (35)
Cancer Prevention and Control$76,066
P30 · FY2025 · CA · contact PI
Implementing a genomics-enabled Learning Health System across Indiana$658,448
U01 · FY2024 · HG · contact PI
Implementing genomic medicine through pragmatic trials in diverse and underserved populations across Indiana.$409,209
U01 · FY2024 · HG · contact PI
Implementing genomic medicine through pragmatic trials in diverse and underserved populations across Indiana.$577,907
U01 · FY2023 · HG · contact PI
MIRA-Regulation of drug metabolizing enzymes$496,125
R35 · FY2023 · GM · contact PI
Cancer Prevention and Control Program$26,840
P30 · FY2023 · CA · contact PI
Implementing genomic medicine through pragmatic trials in diverse and underserved populations across Indiana.$1,479,266
U01 · FY2022 · HG · contact PI
MIRA-Regulation of drug metabolizing enzymes$496,125
R35 · FY2022 · GM · contact PI
Implementing genomic medicine through pragmatic trials in diverse and underserved populations across Indiana.$166,432
U01 · FY2022 · HG · contact PI
Implementing genomic medicine through pragmatic trials in diverse and underserved populations across Indiana.$793,444
U01 · FY2021 · HG · contact PI
MIRA-Regulation of drug metabolizing enzymes$496,125
R35 · FY2021 · GM · contact PI
Implementing genomic medicine through pragmatic trials in diverse and underserved populations across Indiana.$158,489
U01 · FY2021 · HG · contact PI
Implementing genomic medicine through pragmatic trials in diverse and underserved populations across Indiana.$2,468,344
U01 · FY2020 · HG · contact PI
MIRA-Regulation of drug metabolizing enzymes$496,125
R35 · FY2020 · GM · contact PI
Implementing genomic medicine through pragmatic trials in diverse and underserved populations across Indiana.$124,880
U01 · FY2020 · HG · contact PI
Implementing genomic medicine through pragmatic trials in diverse and underserved populations across Indiana.$2,403,712
U01 · FY2019 · HG · contact PI
MIRA-Regulation of drug metabolizing enzymes$496,125
R35 · FY2019 · GM · contact PI
Implementing genomic medicine through pragmatic trials in diverse and underserved populations across Indiana.$391,829
U01 · FY2019 · HG · contact PI
Embedding Pharmacogenotyping in an Integrated Health System for the Underserved$567,161
U01 · FY2018 · HG · contact PI
Regulation of mRNA splicing by intronic genetic variants$558,312
R01 · FY2018 · CA
Implementing genomic medicine through pragmatic trials in diverse and underserved populations across Indiana.$412,750
U01 · FY2018 · HG · contact PI
Embedding Pharmacogenotyping in an Integrated Health System for the Underserved$930,586
U01 · FY2017 · HG · contact PI
Regulation of mRNA splicing by intronic genetic variants$557,164
R01 · FY2017 · CA
Regulation of drug metabolizing enzymes by miRNAs$498,772
R01 · FY2017 · GM · contact PI
Embedding Pharmacogenotyping in an Integrated Health System for the Underserved$80,000
U01 · FY2017 · HG · contact PI
Embedding Pharmacogenotyping in an Integrated Health System for the Underserved$1,050,414
U01 · FY2016 · HG · contact PI
Regulation of mRNA splicing by intronic genetic variants$576,262
R01 · FY2016 · CA
Regulation of drug metabolizing enzymes by miRNAs$484,156
R01 · FY2016 · GM · contact PI
Embedding Pharmacogenotyping in an Integrated Health System for the Underserved$957,981
U01 · FY2015 · HG · contact PI
Regulation of drug metabolizing enzymes by miRNAs$486,378
R01 · FY2015 · GM · contact PI
Regulation of drug metabolizing enzymes by miRNAs$596,082
R01 · FY2014 · GM · contact PI
Regulation of drug metabolizing enzymes by miRNAs$457,603
R01 · FY2012 · GM · contact PI
Regulation of drug metabolizing enzymes by miRNAs$470,153
R01 · FY2011 · GM · contact PI
Regulation of drug metabolizing enzymes by miRNAs$407,458
R01 · FY2010 · GM · contact PI
Regulation of drug metabolizing enzymes by miRNAs$370,881
R01 · FY2009 · GM · contact PI